Heather P. Adams, MPAS, PA-C, Erica L. Carnright, PA-S
Although accreditation for this CE/CME activity has expired, and the posttest is no longer available, you can still read the full article.
Expires September 30, 2014 – Improved understanding of the central role of human papillomavirus (HPV) in cervical carcinogenesis has led to the development of vaccines and DNA testing for high-risk HPV subtypes. But age-appropriate cytologic screening remains the cornerstone in the prevention and early detection of cervical intraepithelial neoplasia (CIN) and cervical cancer. With prompt diagnosis and treatment of both CIN and early-stage cervical cancer, the prognosis for this disease is excellent.
References
CE/CME No: CR-1309
PROGRAM OVERVIEW Earn credit by reading this article and successfully completing the posttest. Successful completion is defined as a cumulative score of at least 70% correct.
EDUCATIONAL OBJECTIVES • Discuss the central role that human papillomavirus (HPV) infection plays in the development of cervical intraepithelial neoplasia (CIN) and cervical cancer. • Instruct patients on contributing cofactors of HPV infection and cervical cancer, including tobacco use, parity, use of oral contraceptives, co-infection with HIV, and immunosuppression. • Describe the current recommendations for cervical cancer screening from professional societies, national health organizations, and federal agencies, including age-appropriate screening for cytology and high-risk HPV. • Explain the timing and administration schedules of the currently available HPV vaccines and the patient populations for which the vaccines have been approved. • Discuss the ablative and excisional procedures used to treat CIN and the treatment options for cervical cancer.
FACULTY Heather P. Adams is an Assistant Professor/Clinical Coordinator in the Physician Assistant Program at Gannon University in Erie, Pennsylvania; in the program, Erica L. Carnright is a Physician Assistant student on clinical rotations.
The authors have no significant financial relationships to disclose.
ACCREDITATION STATEMENT
This program has been reviewed and is approved for a maximum of 1.0 hour of American Academy of Physician Assistants (AAPA) Category I CME credit by the Physician Assistant Review Panel. [NPs: Both ANCC and the AANP Certification Program recognize AAPA as an approved provider of Category 1 credit.] Approval is valid for one year from the issue date of September2013.